O-001 O-002 O-003 O-004 O-005 O-006 O-007 O-008
|
|
- ゆき やすこ
- 7 years ago
- Views:
Transcription
1 é
2 O-001 O-002 O-003 O-004 O-005 O-006 O-007 O-008
3 O-009 O-010 O O-012 O-013 O-014 O-015 O-016 O O-018 VII1 O-019 O-020 O-021 O-022 O-023 O-024 1
4 P-001 P-002 P-003 P-004 P-005 P-006 P-007 P-008 P-009 P-010 P-011 P-012 P-013 P-014 P-015 P-016 P-017 P-018 P-019
5 P-020 P-021 P-022 P-023 P-024 IGFBP-1 P-025 P-026 P-027 P-028 P-029 P P-031 P-032 P-033 P-034 P-035 P-036 P-037 P-038 P-039 P-040 P-041 P-042 P-043 P-044 P-045 P-046 P-047 P-048 P-049 P P-051 P-052 P-053 P-054 MRSAMycotic aneurysm
6 P-055 P-056 P-057 P-058 P-059 P-060 P kg P-062 P-063 P-064 P-071 P-072 P-073 P-074 P-075 P-076 P-077 P-078 P-079 P-080 amniotic sheets 1 P P-066 P-067 P-068 P-069 P-070 P-081 P-082 P-083 P-084 P-085 P-086 P-087 P-088
7 P-089 P-090 P-091 P-092 P-093 P-094 P-095 P-096 P-097 P-098 P-099 P-100 P-101 NICU P P P P-105 P P-107 P-108 P-109 P-110 P-111 P P-113 NICU P-114 NICU2 P-115 P-116 P P-118 NICU P P-120 NMCS NMCS P-121 P-122 NICU 2 P-123 ADHD P-124 P-125 DHA EPA
8 P P-127 Pelizaeus-Merzbacher P-128 Halo scalp ring P P P-131 Hirschsprung P-132 MMI2 P-133 P P P P P-138 Facio-aucurio-vertebral spectrum 1 Goldenhar MM P-139 3PCS Premature Chromatid Separation P-140 Noonan P-141 3q trisomy NICU P-142 Type I IgE P P-144 West P-145 P P q13 P-148 Toriello-Carey 1 P-149 Sotos 1 P P P-152 P-153 Mesodiverticular band 1 P-154 S 1 P P-156 CCAM 3 P P P P P-161 Sengstarken-Breakmore Tube S-B tube1
9 O-025 O O O-028 Klippel-Trenaunay KTS 1 O O-030 GDM O O-032 O-033 O Basedow 1 O-035 O O-037 rapid tocolysis O-038 O-039 VBAC O-040 VBAC O-041 O CDH O-043 ECMO O-044 NO PGE1 vs NO O-045 ECMO O-046 ECMO 11 O-047 MRI O-048 MRI O-049 O-050 O-051 O-052
10 O-053 Bochdaleck O O-055 O-056 O-057 O-058 NICU O-059 AGA SGA O-060 O NICU O-070 O O-072 NICU IgE O O O-075 O-076 O-077 O-078 O-061 O O-063 CHDF O-064 O-065 Very low density lipoprotein VLDL O-066 IGF-1 O O-080 DORV1 O-081 O-082 O O-084 SS-A O-067 BFH O-068 Hold pressure O-085 O-086
11 O O-088 O-089 O-090 NICU O MRI O O-093 TTTS O-094 O-095 O O O098 Stress-Velocity O-099 3D VLBW Stress-Velocity O-100 NT-proBNP O-101 N-terminal probnp NT-proBNP O-102 O-103 NICU NICU O PDA O-105 O-106 O-107 O-108 O-109 IGF-1 O-110 O-111 RetCam 1 O SGA AGA O-113 O-114 O O FMNN O-117 NICU O-118 O-119 O-120
12 O g 3 O-122 O-123 NICU 24 O O O-126 O-127 vascular access O-128 O g2 O-130 PICC NICU O-131 O CMV fetal palliative care Late Preterm Birth LPB 2 Late preterm 3 4 Late-preterm 5late preterm
13 NICU ml 4 NICU VBAC O-133 O-134 Coiling index O-135 pulsation O-136 O-137 Amniotic sheet 1 O NRFS 1 2 3UAE 4 cesarean hysterectomy 5 O-139 O-140 O-141 O-142 O O-144 O-146 O O-148 O-149
14 O-150 IUGR O-151 O-152 Preeclampsia O-153 O-168 CATCH22 1 O O-170 O O-154 L- + h O-155 Th1/Th2 O-156 Reversible Posterior Leukoencephalopathy Syndrome 2 O-157 PIH IUGR O-158 O-159 IUGR cerebroplacental ratio CTG O-172 NST O O O-175 O O-177 persistent cloaca 1 O-160 IUGR O-161 IUGR O-162 O-163 O-164 SGA O-165 severe IUGR O-166 O O O-179 O O-181 O O-183 O-184 O-185 3D
15 O-186 3DCT1 P P-163 P-164 P-165 P-166 Breus` mole P-167 P-168 P P P-171 P P-173 MRI4 P-174 P P P P-178 P-179 CPAP P-180 CPAP 1 P P-182 P-183 P P-185 P-186 P-187 E P P-189 Rh P-190 ITP Upshaw-Schulman 1 P-191 Klippel-Trenaunay-Weber P-192 P-193 P-194 1
16 P-195 P P P-198 S 1 P P-200 Jr a 1 P-201 Light for gestational age infant P-202 P-203 P-204 P-205 P-206 P P P-209 ME P P-211 P-212 P-213 P P-215 NMCS P-216 RSV P-217 NICU PIMS P-218 P-219 NICU P NICU P-221 P-222 P-223 venous angioma P P P-226
17 P P-228 Neonatal Hyperekplexia P-229 P-230 P-231 PVLMRI P-232 DHA P-233 CT P-234 NICU P P-236 PI P P-238 P-239 High CSF Antioxidants and IL8 are protective of Hypoxic Brain Damage in Newborns Hussein Mohamed P-240 HIE Begum Esmot Ara P P-242 NICU P-243 Late-Preterm HIE 3 Term P P P-246 NICU6 P-247 HPA-4b 1 P-248 NICU NITP P P-250 Upshaw-Schulman 1 P-251 A P-252 A 2 P-253 P-254 P-255 TAM 2 P-256 band3 2 P-257 P P-259 glomerulocystic kidney disease 1 P-260 HMGB-1 P P-262 NICU Streptococcus bovis
18 P-263 MRSA18 MRSA P RS P-265 HIV-1 25 P-266 HIV 3 P P P P F-fluoro-L-DOPA PET P-271 P-272 P-273 P-274 P-275 P-276 Gaucher 1 P P P P-280 5b TRACP-5b P P-282 DIC P P P P P P P-289 valve bladder 1 P-290 Potter sequence 1 P-291 P-292 rt-paelbw 1 P P
19 O-187 O-188 Viral-Associated Hemophagocytic Syndrome 1 O HCV-RNA HCV O-190 -T ParvovirusB19 O O-192 IgG avidity PCR NTT O-193 O-194 O-195 O-196 O-197 O-198 RPLS O-199 XY O-200 O-201 O-202 O O-204 O O-206 O-207 O-208 2nd trimester 2 O-209 MFICU O-210 MgSO4 O-211 RCT MGS O-212 O-213 O-214 O-215 O-216 MFICU 32 O-217
20 O O preterm PROM O O-221 Selective IUGR TTTS O-222 O-223 MD O-224 TTTS normal-polyhydramnios13 O-225 TTTS O O-227 MD O-228 TRAP sequence RFA O-229 Selective IUGR O-230 O-231 O-232 O O-234 O-235 NT Nuchal translucency O-236 O-237 X cell-free fetal DNA O-238 O-239 O-240 O-241 NICU aeeg O-242 O-243 O-244 O-245 O-246 IL-6 O-247 O MRI O-249 MRI 1 61 O-250 MRI 1 62 O-251 MRI
21 O-252 O-270 HCV14 prospective study O-253 O-254 NIRS O-255 Microdialysis O-256 O-257 O-258 O Palivizumab O-260 RS DIC O-261 NICU O O-263 APR O-264 O-265 Bifidobacterium bifidum O-266 antimicrobial peptides O-267 O O-269 HIV O O-272 O-273 O-274 O O-276 O-277 O O O-280 CD Clostridium difficile O O O-283 CO O-284 Total Bilirubin O-285 UB
22 O-286 LED O-287 LED O-304 NICU O-305 O-288 Bernard-Soulier 1 O-289 Hb1.8g/dl 1 O-290 C O-291 O-292 rhg-csf O O O-307 CLD3 O O O-310 DCH CLD O-311 O O O O O-298 IGF2-H19 O-299 Campomelic dysplasia 14 SOX9 O NO1 O-313 NO Epoprostenol Sildenafil O-314 NICU O-315 NRPSpO2 O SpO2 O-317 KL-6 D SP-D O-300 O-301 HFO 3 O O-303
教室業績2014
MFICU MFICU : - : - : -,,, : - : -- - : - : - : - - - : - - - - : - : - : - : -, : - Takano Y, Furukawa S, Ohashi M, Michikata K, Sameshima H, Ikenoue T J Obstet Gynaecol Res, : -, CTG - CTG - : - Katsuragi
More information2011 2014 19 22-1 - - 2 - - 3 - - 4 - HIV HIV - 5 - SCU - 6 - ICUHCU NICU NICU HCU NICU ALSO - 7 - T-MRI FISH - 8 - ME NST - 9 - - 10 - da Vinci C C C DPC - 11 - C C C C C C - 12 - C C D D DPC D D - 13
More information2015 3 1.... 1 2.... 2 (1)... 2... 2... 3... 4 (2)... 5... 5... 6 (3)... 7 DPC... 7... 8 3.... 11 (1)... 11... 11... 12... 14 (2)... 15... 15... 16 (3)... 17... 17... 17 4.... 19 (1)... 19 (2) SWOT...
More informationProfessor Emeritus of Surgery, The University of Iowa College of Medicine Ken Kimura
51 3 2015 5 351 52 1 5 28 1 8 55 9 00 9 00 10 30 1 Keynote Lecture RS1-1 RS1-2 RS1-3S OCIAD2 DNA I RS1-4 Kif26A KO RS1-5 RS1-6S TLR-4 IL-4 DEC205 RS1-7S PGE-MUM 10 30 11 20 1 OS1-1 MAPK in vitro OS1-2
More information無印良品 2012 自転車 カタログ
26 897895321,000 140cm 76.0cm 16.0kg H LED 3 263 897896025,000 140cm 76.0cm 16.5kg H 3 LED 20 8978984 8978977 19,800 134cm 73.0cm 15.0kg LED 2620 2620 8486656550 5536207483 14512372,100 8279999840 26 77342561,417
More information教室業績2014
p- p- p- p- : - N-N : - : - : - - : - : - : - : - Katakami H, Hashida S, Oki Y, Murakami O, Ikenoue T, Ono H, Matsukura S Clin Pediatr Endocrinol, suppl : -,. Ochiai H, Ikeda T, Mishima K, Yoshikawa T,
More information04_ポスター.indb
般ポスター基礎超音波計測一般 一般ポスター基礎 6 月 8 日 ( 金 ):00 - :0 ポスター会場 ( 神戸ポートピアホテル B F 座長 : 9- 基 P-00 S790 9- 基 P-00 S790 9- 基 P-00 S79 Jing ZHU, 9- 基 P-00 S79 9- 基 P-005 S79 9- 基 P-006 CT S79 Wenjing WU 9- 基 P-007 HIFU
More information2006年3月8日
18 21 1990 2004 2 2005 14 15 2004 1990 2005 2003 300 7 2 1 2005 1972 100 40 6 1972 2004 197 6,500 2004 21 59 100 65 2007 5 2005 30 1.8 535.89 348.33 187.56 2006 2006 5 1 30 1 30 46 46 1 46 1000kl 4 1 100kl
More informationQOL 02 QOL QOL UI AI EAThoracotomy TTThoracoscopy TS QOL EA type-c y score UI 3 AI 8 School score QOL score 12
54 1 2018 2 4-1 OK-432 1 15 14 15 US CT MRI 17 cm 0.16 g/kg/day OK-432 3 1 ke 2 2 ke 3 1 1,150 ml 13 US OK-432 4-2 TJ-28 TJ-28 2003 3 2017 6 250 TJ-28 44 16 28 TJ-28 7 2 46 8.5 2 2 9 34 79.1 10 23.3 34
More informationMicrosoft Word - ②(添付資料)家庭の夏期節電実態調査の結果について
CO 2 1. 2012 CO 2 CO 2 CO 2 2. 2012 9 28 10 1 8,241 CO 2 3. (1) 2012 2.7%CO 2 1% 1 2 5.8% 3.7% (2.8%)(2.8%) 6 4 5% 1 3 7 5%3 (2) 2012 32%2011 21 (39%)(38%)(37%) 8 2011 (+17.9 ) (+11.9 )(+9.3 )2012 8 (-14.9
More information14 00 14 50 3DO3-1 DO3-5 DO3-1 DO3-2 DO3-3 DO3-4 DO3-5 1 1 2 3 3 3 3 3 3 3 1.2. 3. 15 1 2 3 1. 2. 3. 1, 2 2, 3 1, 2 1. 2. JSEPTIC 3. ICU 1 2 1.2. 医 一
第 1 日 目 第 1 日 目 (2 月 9 日 ) 一 演 題 医 師 部 門 演 第 6 会 場 ホテル 日 航 東 京 3F レインボーテラス 9 00 9 50 1 DO1-1 DO1-5 DO1-1 DO1-2 DO1-3 DO1-4 DO1-5 Presepsin LPS PGC-1 1 2 3 2 3 1 1. 2.3. Critical illness polyneuropathy
More information23 3 11 14 46 9.0 7 10m 40.1m 15,883 2,681 25 4 10 39 40 800 180 24 2425 22 21 24 5 3 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213
More information教室業績2014
Salmonella Agona MRI Noor JI MD : MD-twin score : p- : - : - NEW : - NEW NEW : - : - NEW : - NEW : - NEW : - NEW : - : - : - : - : - : - : - : - : S -S Clinical OB-Gyne : - : S -S : - Sameshima H Ikenoue
More information10 44 1.2 5 4 5 3 6-1 - 1 2 3 4 5 1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8 9 10 TEL TEL 1 2 TEL FAX TEL FAX TEL FAX 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 1 2 3 4 5 6 ( ) ( ) 2
More information() 2
1 () 2 2 4 3 6,500 4 5 2 6 A B A B A B A B - A B 7 8 A B A B A B 9 JR JR 10 11 6 5 12 17 6 13 14 B A A B A B A B 2 1 8 15 8 16 17 9 18 3 4 5 mm mm 19 2 20 3 6 7 11 12 13 14 18 4 3 2 1 21 3 12 13 14 16
More information幼保連携型認定こども園 教育・保育要領解説
1 1 1 2 1 2 2 5 3 6 4 6 8 8 1 8 2 11 15 1 16 2 17 3 17 4 18 18 23 23 1 24 2 25 3 30 4 30 5 38 6 42 42 45 1 45 2 46 65 65 1 65 2 70 3 71 4 78 5 80 84 1 84 2 87 3 92 4 112 115 1 115 2 120 122 122 124 126
More informationサンプル一覧表.PDF
: 1 30 1 : 1 30 : 8662 60 : 4810 30 1 : 19383 90 : 8872 : 6279 : 7098 180 120 90 : 6405 120 : 7234 :3276 60 280 : 8053 180 : 5512 180 : 4368 100 :4462 120 : 4725 120 : 8851 180 : 3024 180 : 3286 150 :
More information市区長選挙における民主党の戦略
. , -,,, a, .......................................................... -,,, b b .............................. .. ,. %,,,,, JR TUBE TUBE TUBE TUBE ,. %,,,,,,,,,,,,,,,,,,,, ,. %,,, a, b - - -- pp a b
More information35 縮小版 和 .indd
2 3 4 5 6 7 8 9 10 11 12 22:46 Co Spd 17.0 kts 23:02 Co Spd 17.0 kts 22:30 Co Spd 8.5 kts 23:02 Co Spd 8.5 kts 22:08 Co Spd 8.0 kts 23:07 Co Spd 8.0 kts 23:02 Co
More information1 2 2 4 6 6 6 7 7 7 8 8 8 13 15
2014/09/30 1 2 2 4 6 6 6 7 7 7 8 8 8 13 15 40 50 46 40 23 3 11 28 4 4 1 30 6 11 31 5 32 4 7 16 4 22 4 29 30 4 46 12 47 10 56 4 13 12 15 100 20,312 7,609 12,703 3 3,086 723 280 46 47 46 FRP 835 25m11.5m
More informationpp doi: /jjsps.54.6_ The 34th Autumn Symposium of The Japanese Society of Pediatric Surgeons
54 6 2018 10 pp. 1173-1193 doi: 10.11164/jjsps.54.6_1173 1173 34 The 34th Autumn Symposium of The Japanese Society of Pediatric Surgeons 30 2018 10 27 10-1 3-6-2 HP URL https://psjm2018.com/ 34 PSJM2018
More information’¸’_Ł\”ƒ1-4fiñŒÊ
20 23 2011 1 23 24 10 2010 26 11 20 27 12 29 13 22 35 14 2010 36 15 44 23 3 11 23 27 1 11 46 14 188 14 2 16 22 97 3 2 7 3 30 80 19 22 10 1 37 796 4 3 20 30 30 23 3 30 19 4 1 4 8 1 2 4 5 2010 73 22 7 19
More information評価結果報告書の概要版(平成20年度)
10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76
More information表紙030313.PDF
H2 CO (1) (3) (4) () () ( ) ( : 11 ) [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ]......... [ ] [ ] [ ] [ ] [] [ ] [ ] [ ] [ ] (g) [ ] ) [ ] [ [ ] [ ] [ ] ) ) ) )... [ ] [] [ ] [] [ []........
More information小児内分泌学会-03-プログラム.indd
10 2 8 30 9 55 SOP 2 P-044 P-045 2 P-046 :Frasier 1 1 1 1 1 1 2 2 1 1 2 P-047 GH 1 1 2 2 2 2 2 1 2 P-048 Bartter 1 1 1 1 2 1 2 P-049 SD IGF-1 GHD P-050-2SD GHD 1 2 2 2 1 2 P-051 GHD 1,2 1 1 1 1 1 2 2 3
More informationリサイクルデータブック2016
AppendixEU SDGs2159EU 21512UNEPOECD2165G7 2165 213 Appendix 1 EU 2 EU 3 215 i CONTENTS i 1 213 1 213 2 1 4 2 2 6 3 3 6 4 213 7 4 5 9 6 213 9 5 7 1 8 213 1 9 11 1 213 11 11 213 11 6 6.1 12 213 14 6.2 13
More informationMicrosoft Word - EA21環境活動レポート18.3.31.(5.30..doc
2005 2 15 9 12 1 2 15 3 TEL 03 5755 7031 FAX 03 5755 7036 30 1089.74 1 3 31 2 2004 2006 2 kg-co2 kg 2003 2004 2005 2006 2003 200,117 183,471 181,636 180,105 10 48,150 52,169 48,233.5 44,298 8 331 263 255.625
More information13 6 2 68 34 JIS S0026 JIS JIS S0026 50000 2550mm 2550mm 2550mm 12 1 4 15 ( ) 3000 1 1 H17 ttp://www.isuzu.co.jp/product/bus/gala_ss/approach.html
More information<836C83628367834A8374834692B2B895F18145706466>
1. 30 5 500 2 7 100 2 10 100 2007 4 1 7,200 6,800 7 NPO 1,200 1 12 15 2 1.5 0.5 30 2 24 5 27 16.8 28 2.3 10,500 / 3 3,800 117 2 3 6 6,000 1 1 1 2 2006 1 6, 000 + + 8 30 17 00 7.5 13 2 B2 2. 50 2 3 1 1
More information156 51 1 2015 2 3 6 1 1) 2) 3) 1) 1) 1) 1) 1) 2) 3) 3) 3 1 4 6 2 3 4 Rocky Mountain Soap Rocky Mountain Soap RMS Canmore Banff Pure hand-made 100 toxi
51 1 2015 2 pp. 155-173 155 25 QOL 26 10 18 1993 2000 23 25 3 IT 10 2 end of life living will living will living will 1 NICU QOL NICU QOL 3 6 kg NICU 42 2 kg 2007 NICU 2 NICU/ GCU 25 4 26 3 3 A 156 51
More informationuntitled
59 2014 7 12 59 2014 7 12 59 171 3F 2F 1F B2F B3F B2F 1. 2. 3. 1 2 3 9 00 10 00 11 00 9 00 9 30 9 30 9 40 9 40 11 40 9 40 10 50 1 10 50 12 00 D1 1 D1 7 3 D3 1 D3 7 9 40 10 50 2 10 50 12 00 D2 1 D2 7
More informationml DNA DNA
ml DNA DNA ml PH HO DNADNA DNA LED LED CD CD ch 概 概 mll IC LED OK CD CDDVD CD LED LED LED The LED PVA Part LED LED PPT V LED AI LED V AlCu Fe Al Al PVA ml 概 概 CD CD OHP etc cm PET cm PET cm PET LED LED
More information天草郡市医師会第139回(臨時)代議員会
A 97 2(B A2) 4(A B3) 2 95 B 104 25(A B3) 16(B A2) 9 113 201 27 20 7 208 2 1 13 3 18 4 19 3 3 2 2 13 4 17 3 18 6 26 6 30 17 18 17 17 17 17 18 ( ) 18 ( ) 18 ( ) 18 ( ) 18 ( ) ( ) ( ) ( ) ( ) ( ) 18 ( ) (
More informationリサイクルデータブック2017
AppendixEU SDGs2159EU 21512UNEPOECD2165G7 2165 214 Appendix 1 EU 2 EU EU( EU EU EU EU 3 217 i CONTENTS i 1 214 1 214 2 1 4 2 2 6 3 3 6 4 214 7 4 5 9 6 214 9 5 7 1 8 214 1 9 11 1 214 11 11 214 11 6 6.1
More information() 90
1 () 90 15 I 20 20 1 8.5 6.2 AED 17.5 10 9.810 4.5 119 1 119 VF VF 710 CPR 119 119 1 1 3 119 3 180 240 480 24 8 24 16 3 3 1 4 8 119 AED AED 1 8 1 3 1 4 5 3 2 2 AED 3 119 AED 119 AED 119 10 100 30 2 30:2
More informationPSCHG000.PS
FA X IT FA X c c c c cm RSA cprsp c http:w ww.pref.m iyazaki.jpfukushiipeindex.htm l, http:w ww.kenkomap.com m iyazaki Walking Sm oking GDP GDP e f e f e GDP f GDP IT GDP GDP GDP e f GDP GDP GDP
More information橡Taro10-大豆研究図表込み.PDF
100 t 48 19 12 500 t 1960 28 90 2 3 1960 64 75 15 1987 29-55- 4,386 3,453 825 208 617 9 55 5,017 3,898 945 189 464 89 203 8 70 4,821 3,630 994 196 494 107 197 8 95 4,628 3,426 1,013 193 494 108 218 7 95
More informationw
11 No.469 NOV. 200214 w e r 7 t k k H H y u i Y o !0 Y Y Y Y Y Y!1 1 1!2 !3 a!4 b!5 !6 B 1 1 1 1 b b !7 f 1 1 !8 1 11/ G 1 R u u u u u u u u u u u u ub u u u u u uc u u u u s s s s s s s s sb s s!9 c Y
More informationPhD HIPAA sports nutrition coach ACE ISSN Sports Nutrition Specialist Certification ISSN CISSN IOC IOC 3
1 9 2017-05-06 Marie Spano, MS, RD 185 AND CSSD 2 9 2017-05-06 PhD HIPAA sports nutrition coach ACE ISSN Sports Nutrition Specialist Certification ISSN CISSN IOC IOC 3 3 136 EPA D 46 B12 B12 B12 2010 98
More information本文01id5.indd
1 TFT 9F 906 907 907 1 TFT 9F 906 90 1 P1-01 P1-02 1 1 1 2 1 1 2 P1-03 P1-04 P1-05 4 P1-06 P1-07 P1-08 1 1 1 2 1 2 P1-09 VCM TDM VCM 1 2 2 2 3 3 4 5 1 2 3 4 5 2 P2-01 P2-02 P2-03 83 1 TFT 9F 906 907 906
More information10 2 2 10 6.5 78 1 65 / 30 / - 2 -
- 1 - 10 2 2 10 6.5 78 1 65 / 30 / - 2 - 3 3 30 8 4 8 6 11 14 45 14 7 8 1-3 - 4 1 () 20 4 9 4 9 3 9 4 PR 4 3-4 - - 5 - PR 15 4 PR 7 8 4 9 10-6 - 9 10 9 10 4 9 10 3 9 10 9 9 9 10 PR 1-7 - PR - 8 - 30 100-9
More informationGeneral Instructional ObjectiveGIO Specific Behavioral ObjectivesSBOs (1) (2)
General Instructional ObjectiveGIO Specific Behavioral ObjectivesSBOs (1) (2) (3) (4) (Standard Precautions ) (5) ( ) (6) (7) ( ) ( ) QOL(Quality of Life) ( ) (8) 1 2 (1) (2) (3) 4 24 (4) 3 ABC3 (common
More information2
5 15.8% 17.1% 13.7% 15 1 34.0%3 1 3 25.7 4 1 76.5 3.3 2 23 3225 36 72.0 13.3 1 26 38 ( 77.8 87.8 69.5 2010 3 20 60 7 20 2 3 1 2 ( 77.8 87.8 69.5 2010 87.9 66.5 3 20 83.030 92.240 93.6 50 91.660 6065 72.9
More information長崎県県央保健所事業概要
P1 P2~P3 P4 P5 P7~P10 P11~P40 P41~P174 P175~P179 P181~P212 271,417 2 3 4 5 5 7 8 9 10 12 13 14 15 16 18 19 2,506 365 293 5 20 2 4 123 4 17 1 2 143 351 5 3 18 40 10 475 3 2 22 22 66 1 13 18 31 10
More informationuntitled
28 20 1 31 4 2 25 1 IgG IgA IgM IgE IgM 2 60 80 70 60 60 40 20 80 35 45 kg 150cc 100 120cc 100cc 30 40cc 7,000g 500cc 120cc 120 5=600cc 600g 30 2,100cc 1,000cc 3 4 14 5 6 7 8 9 10 11 12 SIDS SIDS SIDS
More information67.5km 299.4km 2 2 2 16km 1/6 47km 2 1 1 (m) (km 2 ) 2,700 7.6 9,927 47.1 8,100 13.4 8,120 4.8 52 0.4 1,100 6.0 2,200 3.8 6,982 45.3 4,473 14.4 5,000 9.5 2 (km 2 ) (km) 1 299.4 67.5 2 284.5 38.8 3 267.0
More informationuntitled
20 7 1 22 7 1 1 2 3 7 8 9 10 11 13 14 15 17 18 19 21 22 - 1 - - 2 - - 3 - - 4 - 50 200 50 200-5 - 50 200 50 200 50 200 - 6 - - 7 - () - 8 - (XY) - 9 - 112-10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 -
More informationuntitled
19 1 19 19 3 8 1 19 1 61 2 479 1965 64 1237 148 1272 58 183 X 1 X 2 12 2 15 A B 5 18 B 29 X 1 12 10 31 A 1 58 Y B 14 1 25 3 31 1 5 5 15 Y B 1 232 Y B 1 4235 14 11 8 5350 2409 X 1 15 10 10 B Y Y 2 X 1 X
More information救急車同乗実習レポート 総括
14 9 1 9 10 10 19:00 23:00 52 1 6.5 40 CT X CT Ope 15 /min BP 100/70mmHg HR 96 /min O U m 60 25/min BP 140/80mmHg HR 55 O Spo 98 BP 172/68mmHg O 30 15 /min BP 100/60mmHg HR 80 /min BS O O CO 30 40 JCS
More information日本医師会雑誌第131巻第10号
B C 100 12 11 13 3 C 4 C Q&A B C 54 B B B B Q&A B B HBV 20 HBV B B B B HBV HBV HBV HBV 2 HBV HBV HBV A HBV HBV HBV HBV HBV Q37 HBV HBV HBV 1015 B B B Q51 B HBV B B HBV B HBV HBV HBV B B B HBV B HBV HBV
More information2004 10 2004 1984 2 1986 4 20 60 1 3 1 1 1 13,300 2 2 2 3 1 2004 2009 2 1 1 2 1 1985 97JR JT NTT 2002 96 97 4 JR JT 97 3 JR 19 29 JT 2.4 2.5 JR JT NTT JR JT NTT 2 97 4 JR 20.09 JT 19.92 NTT 17.35 17.35
More information89 91 93 95 97 99 101 103 105 107 109 111 113 115 H 117 119 l l 121 l l 123 125 127 129 l l l l 131 kl kl kl kl 133 135 137 139 141 143 145 147 149 151 153 155 157 159
More information株式会社日清製粉グループ本社 第158期中間事業報告書
C O N T E N T S...1...3...5...7...9...11...12...13...14 1 2 3 4 3.7% 5.8% 8.5% 70,100kL 81.2% 0.8% 25 20 15 10 5 0 9.18 9.54 9.74 9.62 9.65 9.71 21.04 21.97 22.44 22.23 8.54 22.31 22.45 20.41 15 12 9 6
More information1. 3 2. 2 7 3. 10 4. 12 5. 15 6. 18 7. 21 8. 24 9. 28 10. 31 11. 34 12. 38 13. 41 14. 44 15. 47-1 - 16. LET S TRY 50 17. 52 18. 55 19. K 58 20. TAWASHI 62 21. 65 22. 68 23. 72 24. Student Venture Project
More information2001 2003 2005 2006 2007 2008
2001 2003 2005 2006 2007 2008 60 etc. http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8% AAN 65
More information0400908ヲ医大ニュース80/医大ニュース第80号PDF
2004 8 80 1 No.80 2004.8 TEL FAX 15 3 24 105 15 5 3 5 14 4 99 67 51 16 16 4 6 100 90 3 15 6 4 7 72 4 5 30 15 15 15 H16.3.24 16 H16.4.6 15 H16.3.5 2 2004 8 80 54 1979 4 25 56 20 1500 10 5cm 1 500 10 50
More informationA A
3 A B C A A 2 5 1 62 A 1 1 2 63 3 1 A proven invasive fungal diseases 1 2 3 BAL 24 : Fusarium spp. 4 2 : Candida Trichosporon B probable invasive fungal diseases Cpossible invasive fungal diseases 5 1
More informationCore Ethics Vol. : - NICU : : - A B C D
Core Ethics Vol.,NMR...... Core Ethics Vol. : - NICU : : - A B C D b: Duff and Campbell A B C: D : a B C b Core Ethics Vol. : -, : C D :.. D.. bd D CD AB CD : Duff C b C B : Core Ethics Vol. C D B A D
More information41-6_50回中国地方会Pr6N__HP掲載用.indd
2014 9 6 1, 2, 2, 2, 2 1, 2 60.. CT S 5 47 mm, 20 mm. US,,..,,. CT.,,.,. 8.,,.,. 1, 2, 2, 2, 2, 2, 3, 3 1, 2, 3 70 5,, CT. 17, 20, 30..,. Segmental Arterial Mediolysis SAM,.,. SAM,., 50,.,, 70. S 5 SOL.
More informationPowerPoint プレゼンテーション
0 1 2 3 4 5 6 1964 1978 7 0.0015+0.013 8 1 π 2 2 2 1 2 2 ( r 1 + r3 ) + π ( r2 + r3 ) 2 = +1,2100 9 10 11 1.9m 3 0.64m 3 12 13 14 15 16 17 () 0.095% 0.019% 1.29% (0.348%) 0.024% 0.0048% 0.32% (0.0864%)
More information23 3 11 24 21 24 25 4 28 4 2 7 161 2,692 28 12 14 18 18 380 5 3 1 27 21 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213 640 416 82,979
More information抄録_46回中国地方会37-6_責.indd
46 22 9 11 Update 46-1 Gd-EOB-DTPA MRI EOB-MRI HCC dysplastic nodule DN 146 62 146 123 HCC 23 DN B hypoechoic 67 46%hyperechoic 79 54% bright loop 14% A dynamic MDCT iso density EOB-MRI 24 B CT low density
More information051
June THE JAPANESE JOURNAL OF ANTIBIOTICS 57 3 295( 83 ) NTT 1. 2. 3. 4. CHOP-R 5. DNA 1 296( 84 ) THE JAPANESE JOURNAL OF ANTIBIOTICS 57 3 June 3 1 2003 10 4 1 NTT June THE JAPANESE JOURNAL OF ANTIBIOTICS
More information…GŒÆ›u››‘KŒâ‚è_cs1.indd
1 1-1 4 1-2 a. b. c. d. e. 1-3 A. 4 B. 3 1-4 a. b. c. d. e. 1-5 1-6 4 1-7 a. b. c. d. e. 1-8 a. b. c. d. e. 1-9 1-10 A. 2 B. C. 1-11 a. / 2 b. / c. / d. / e. / 1-12 a. T b. c. M d. e. 1-13 1-14 1-15 16
More information名称未設定-2
Contents 1 2 3 4 5 6 7 8 9 1 11 12 13 14 15 16 17 18 19 2 21 22 i 23 24 25 26 27 28 29 3 31 32 33 34 35 36 37 38 39 4 41 42 43 44 45 46 47 48 49 5 51 52 53 54 55 56 57 ii 58 59 6 61 62 63 64 65 66 67 68
More information01-3 目次 .xls
119 6 (170 ) 5 4 3 2 1 F F WC -1-2 -1-2 C C A P D 612 (1B) 613 (1B) 615 (1B) 616 (1B) 617 4B 611 B 610 B 608 B 607 B 606 B 605 B 603 B 602 B 601 (1B) 512 (1B) 513 (1B) 515 (1B) 516 (1B) 517 4B 518 (1B)
More information001 No.3/12 1 1 2 3 4 5 6 4 8 13 27 33 39 001 No.3/12 4 001 No.3/12 5 001 No.3/12 6 001 No.3/12 7 001 8 No.3/12 001 No.3/12 9 001 10 No.3/12 001 No.3/12 11 Index 1 2 3 14 18 21 001 No.3/12 14 001 No.3/12
More informationml ml ~ml : ml
ml ml ~ml : ml , ) RI CT MRI( MRI (T2T1 MRI MR Mokri Mokri Mokri ICHD-II) Schievink post-lumbar puncture headache) 1938 Schaltenbrand spontaneous aliquorrhea( 1958 Shenkinlow cerebral spinal fluid pressure
More information4 A) (OECD,2005) 78.4 85.3 (WHO,2002) B) 5 A) B) C) 1 7 2
5 2006 9 1 A) 1 2 3 4 B) 1 2 3 4 5 2 A) GDP 7.9 B) 31 25 8 10 1 45 3 31 8 2 70 1 4 A) (OECD,2005) 78.4 85.3 (WHO,2002) B) 5 A) B) C) 1 7 2 1.6 3 31.1 4 2 5 3 4 CT MRI PET 1 30 A) 1 2 6 B) 1 2 3 4 5 3 90.5
More information